Page last updated: 2024-12-06

amphenone b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Amphenone B is a synthetic compound that acts as an inhibitor of steroid biosynthesis. Its mechanism of action involves blocking the enzyme 11β-hydroxylase, which is essential for the production of cortisol and aldosterone. Amphenone B was initially studied for its potential therapeutic applications in the treatment of Cushing's syndrome, a condition characterized by excessive cortisol production. However, its clinical use was limited due to its significant side effects, including adrenal insufficiency and hepatotoxicity. Despite its limited clinical use, Amphenone B continues to be studied for its potential applications in research, particularly in the development of new drugs for the treatment of steroid hormone-dependent diseases.'

amphenone B: was MH 1975-92 (see under BUTANONES 1975-90); use BUTANONES to search AMPHENONE B 1975-92 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID17591
CHEBI ID2678
SCHEMBL ID8333956
MeSH IDM0198142

Synonyms (18)

Synonym
2686-47-7
amphenone b
C07616
3,3-bis(4-aminophenyl)butan-2-one
AC1L2AAH ,
2-butanone, 3,3-bis(4-aminophenyl)-
unii-y2yun941sl
y2yun941sl ,
3,3-bis(4-aminophenyl)-2-butanone
amphenone b [mi]
amphenone
2-butanone, 3,3-bis(p-aminophenyl)-
CHEBI:2678
SCHEMBL8333956
surecn8333956
DTXSID70181370
amphenon b
Q27105763
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
diarylmethaneAny compound containing two aryl groups connected by a single C atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-199019 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.54 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]